Braskem stock
BAKNYSEBraskem S.A., Basic MaterialsISIN US1055321053
30Score 30 out of 100, Weak
Price and trend
27 / 100
Price history
−62% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 61% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 28).
The price is 77% below its 52-week high. Largest decline in 20 years: 97% (October 2017 to November 2026).
Chart figures for advanced users
- SMA 50$1.57
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$2.92
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)28
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.06
- The lowest closing price of the last twelve months.
- Resistance$5.02
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Braskem S.A. belongs to the Chemicals industry (Brazil) and, with a market value of $450.29M, is number 41 of 44 companies in its industry on MEQIRI.
- This is an American depositary receipt (ADR).
- In fiscal 2025 it reported revenue of $12.34B (down 10.4% year on year) and a loss of $1.72B.
Show more
- MEQIRI Score 30 out of 100 (Weak): rank 437 of 461 in Basic Materials, median 57.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Margin fallingOperating margin −5.7%, average of the prior years 6.3% (to 2024).Profitability 18
- Loss-makingLoss of $986.31M over the last 12 months.Fundamentals 27
- Share price fell sharplyDown 62% over the last 12 months.Momentum 12
Its standout strength is valuation, while stability and momentum hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 31 to 30.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price far below its 52-week high
- weak fundamentals
- high price swings
What lowers it
- price not overheated over the past year
Valuation
Valuation signal
Possible value trapNo fair value can be calculated for this stock, so the signal follows the valuation grade.
Possible value trap: looks cheap, but score below 50, high risk, weak balance sheet.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue fell 9.2% on the twelve months before. Revenue has grown solidly since 2006, at about 9% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 2%, operating −6%, net −14%. Last 12 months: net −8%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 18 Mar 2027in 125 days
- Last reported
- 13 Aug 2026in line with expectations
Analyst estimates
- Earnings per share
- 5.72+15.1%
- Revenue
- $13.45B+0.3%
- Earnings per share
- −6.17−10.2%
- Revenue
- $12.99B+1.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook lowered
Share price after the results: −2.9%External consultants expect a 59% decrease for Brazilian PE naphtha between the second and third quarter, and demand in Brazil is lower than initially expected.
“With regards to Brazilian PE naphtha, external consulting firms expect a 59% decrease between the second and third quarters of '26, given that a reduction in arbitrage between the United States and Asia is expected starting in the third quarter.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 14 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Braskem
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 30
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Green PlainsGPRE $961.13M49
- LSB IndustriesLXU $840.27M51
- Westlake Chemical PartnersWLKP $764.29M69
- SGL CarbonSGL.DE $669.31M48
- ValhiVHI $475.8M47
- Tronox HoldingsTROX $418.43M24
- Selena FMSEL.WA $324.52M76
- PCC RokitaPCR.WA $315.03M52
ETFs that hold Braskem
Held by 1 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Emerging Markets Equity UCITS ETF USD AccAVEM | 0.00% | 0.35% | €284.54M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = R$5.6169)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.